Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome reduces effectiveness of hair loss treatment.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

No treatment fully prevents hair loss from chemotherapy yet.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Long-term use of finasteride may cause breast cancer in men.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common side effect of hormone treatments for cancer.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Neurosteroids help protect the brain and improve behavior after a stroke in mice.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.